Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

Y0001982

Lacosamid

European Pharmacopoeia (EP) Reference Standard

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C13H18N2O3
CAS-Nummer:
175481-36-4
Molekulargewicht:
250.29
UNSPSC-Code:
41116107
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

lacosamide

Hersteller/Markenname

EDQM

Anwendung(en)

pharmaceutical

Format

neat

Lagertemp.

2-8°C

InChI

1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1

InChIKey

VPPJLAIAVCUEMN-GFCCVEGCSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Lacosamide EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

Y0001972

Lacosamid Unreinheit A, European Pharmacopoeia (EP) Reference Standard

Y0001989

Lacosamid Unreinheit F, European Pharmacopoeia (EP) Reference Standard

Y0001973

Lacosamid für die Systemeignung, European Pharmacopoeia (EP) Reference Standard

Y0002065

Lacosamid Unreinheit D, European Pharmacopoeia (EP) Reference Standard

1357125

Lacosamide Related Compound B, United States Pharmacopeia (USP) Reference Standard

1357170

Lacosamide Related Compound F, United States Pharmacopeia (USP) Reference Standard

1357147

Lacosamide Related Compound D, United States Pharmacopeia (USP) Reference Standard

1357158

Lacosamide S-enantiomer, United States Pharmacopeia (USP) Reference Standard

1357103

Lacosamide CV, United States Pharmacopeia (USP) Reference Standard

Piktogramme

Exclamation mark
GHS07

Signalwort

Warning

H-Sätze

H302

Gefahreneinstufungen

Acute Tox. 4 Oral

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 8

1 of 8

vibrant-m

Y0001004

Dydrogesteron

Rufinamid ≥98% (HPLC), powder

Sigma-Aldrich

R8404

Rufinamid

Oxcarbazepin Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1635

Oxcarbazepin

Zonisamide sodium salt ≥98% (HPLC), powder

Sigma-Aldrich

Z2001

Zonisamide sodium salt

Leflunomid Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1378

Leflunomid

Brivaracetam-D3 solution 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

Supelco

B-063

Brivaracetam-D3 solution

Oxcarbazepin ≥98% (HPLC), solid

Sigma-Aldrich

O3764

Oxcarbazepin

Lamotrigin ≥98%, powder

Sigma-Aldrich

L3791

Lamotrigin

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.